Researchers
Real-world immune trajectories
Longitudinal single-cell and multiomic data from healthy adults and people with autoimmune disease, grounded in clinical context. Access existing datasets or assemble a custom cohort focused on the biology you want to understand.
Request dataHigh resolution, multidimensional, clinically meaningful
Precision medicine depends on understanding how biology changes in real people—not just what it looks like at a single moment. Onyx follows people through infection, inflammation, and treatment, capturing their molecular responses with single-cell and multiomic assays. The result is richer context and higher-resolution data for patient stratification, biomarker discovery, treatment-response prediction, and models reflecting real-world human biology.
Clinical context
We provide data from patient-derived samples, not just cell lines growing in an academic lab.
Targeted cohort assembly
We quickly assemble cohorts that satisfy granular critical criteria necessary for clinical development.
Longitudinal sampling
Our studies collect data over time and around key clinical events, such as changes in treatment, vaccination, or infection.
Use cases
Causal biology
Moving beyond correlation with longitudinal data that enables causal analysis of the biology underlying immune system health and disease.Endotyping
Mechanistically understand disease subtypes and predict differential response to medicines.Precision immunology
Validate targets and match immune-targeting therapies to the right patients based on their specific molecular and immune profile.Biomarker discovery
Identifying the molecular signatures that predict disease onset, progression, and treatment response.Patient stratification
Group patients by shared biological signatures to predict who will respond to a treatment and who won’t.
assays
Data analytics capabilities
We generate rich multiomic datasets at single cell resolution, coupled with clinical and live cell phenotyping to provide a holistic picture of immune function
Proteomics & Metabolomics
Proximity extension assays quantify roughly 1,000 plasma proteins at scale, while ultra-sensitive immunoassays capture low-abundance immune signaling molecules (IL-5, IL-6, IL-33 and others) central to autoimmune inflammation. Targeted mass spectrometry adds quantitative metabolite coverage.
Clinical Data
Longitudinal clinical records, linked to every sample at the participant level. Disease activity, medications, and outcomes are tracked across timepoints, so molecular signals can be tied to what is happening in the patient.
Single Cell Transcriptomics
Single-cell RNA sequencing resolves immune cell states that bulk assays average away. Each cell's gene expression is linked to its T or B cell receptor identity for clonal tracking, and to its chromatin accessibility, showing which regulatory programs are active.
Genomics
Genetic variation and regulatory architecture, mapped to the cell types where they act. Connects risk loci to the immune pathways and cell states measured in the same patients.
We partner with leading research labs, AI model developers, and biopharma companies to turn real-world patient data into next-generation drug discovery and development programs.